Meet with us at Rare Trials Summit 2026!
Join us at Rare Trials Summit 2026, where biopharma leaders, patient advocates, investigators, CROs, and technology partners come together to address the unique challenges of rare disease clinical development.
With experience across 88 rare disease indications, including rare cancers and ultra-rare conditions, Premier Research helps sponsors navigate regulatory, operational, and patient recruitment challenges through integrated expertise in study design, global clinical operations, and patient engagement.
Featured Session:
Track 2 – Operational Efficiency in Rare Disease Trials
Afternoon Set: Flexible Evidence and Lean Execution
Fireside Chat: Pediatric Rare Disease Development: Evidence, Flexibility, and Regulatory Pathways. A discussion of pediatric rare disease development, evidence generation, accelerated pathways, and practical considerations.
- Date: Tuesday, September 15 | 1:45–2:30 PM EDT
- Panelists:
- Angi Robinson, Sr. Vice President, Specialty Areas, Premier Research
- Jennifer McKenzie, MD FAAP FASN, Senior Clinical Program Leader, Boehringer Ingelheim
- Janet Maynard, MD MHS, Director, Office of Rare Diseases, Pediatrics, Urologic and Reproductive Medicine, FDA
Connect with our team to learn more about:
- Regulatory strategy and orphan drug development
- Innovative study design and natural history studies
- Patient recruitment, engagement, and retention
- Global clinical operations for complex rare disease trials
On-Site
- Paul Spreen, Chief Commercial Officer
- Angi Robinson, Sr. Vice President, Specialty Areas
- Jenny Anderson, Vice President, Go to Market Strategy & Operations
- Paulla Dennis, Executive Director, Program Strategy, Specialty Areas
Fill out the form above to schedule a meeting with our on-site team.
Let’s discuss how our rare disease expertise can help move your program forward.
